Drover's News

FDA Continues to Address Antiparasitic Resistance in Livestock

The U.S. Food and Drug Administration continues to work with stakeholders to address antiparasitic resistance in livestock (cattle, sheep, goats, swine, and poultry) and horses. In an on-going effort to help maintain the effectiveness of approved antiparasitic drugs, the FDA has produced two videos on antiparasitic resistance; released the results of a survey of the U.S. veterinary community about antiparasitic drug use and antiparasitic resistance in grazing animals; and asked animal drug companies to add information about antiparasitic resistance to the labels of all approved antiparasitic drugs for livestock and horses.

Parasite infections are a health and welfare concern for livestock and horses. Therefore, effective antiparasitic drugs are vital to the animal health industry in the U.S. However, parasites are becoming increasingly resistant to drugs that were generally effective against them in the past. In these situations, after an animal is treated with an antiparasitic drug, the susceptible parasites die and the resistant ones survive to pass on resistance genes to their offspring.

Although antiparasitic resistance in animals doesn’t directly affect the health of people in the U.S., it’s a growing animal health threat in this country and can result in production losses in food-producing animals. Heavy parasite infections can cause diarrhea, weight loss, anemia (low level of red blood cells), and death in animals. Antiparasitic resistance also poses a significant threat to the sustained effectiveness of antiparasitic drugs.

Science shows that antiparasitic resistance can’t be stopped. Parasites will continue to evolve and develop resistance; however, this natural process may be slowed down. The FDA’s strategy to address antiparasitic resistance aims to promote the sustainable use of antiparasitic drugs in livestock and horses to help slow the development of antiparasitic resistance in these animals. This, in turn, will help ensure that antiparasitic drugs remain effective for as long as possible.

Within the last two years, the FDA has accomplished the following to spread awareness about antiparasitic resistance:

  • Produced two videos for animal producers and owners on antiparasitic resistance.

The survey, which focused on cattle, sheep, goats, and horses, collected information for the first time from U.S. veterinarians and veterinary parasitologists to find out: 

  • Their current level of awareness of and concern about antiparasitic resistance in grazing animals;
  • Which strategies they commonly use to detect, monitor, and/or manage parasites and antiparasitic resistance; and
  • Their opinions about the best ways to ensure the safe and effective use of antiparasitic drugs.

The FDA hopes the survey results will facilitate dialogue between animal drug companies, researchers, regulators, educators, and animal owners regarding ways to minimize the development of antiparasitic resistance.

In July 2018, the FDA presented part of the survey results at the annual meeting of the American Association of Veterinary Parasitologists. 

Requested that animal drug companies voluntarily revise the labels of drugs intended to treat certain internal parasites in livestock and horses to add information about antiparasitic resistance.

The requested labeling changes specifically affect anthelmintics used in livestock and horses. Anthelmintics, often called dewormers, are antiparasitic drugs that treat certain internal parasites, such as roundworms. Resistance to dewormers is particularly concerning in grazing species (cattle, sheep, goats, and horses), but it is also a problem in swine and poultry. The new labeling information emphasizes these important points:

  • Any use of a dewormer can result in the development of antiparasitic resistance.
  • Proper dosing is critical to the safe and effective use of a dewormer.
  • End-users should work with their veterinarian to monitor herds and flocks to determine the extent of antiparasitic resistance on a particular farm.
  • Dewormers should be used as only one part of an overall internal parasite control program.

The FDA made this request in December 2018 to all drug companies with approved dewormers (both over-the-counter and prescription) for livestock and horses. So far, over one-third of the companies have added the new labeling statements to their products.

The agency will continue working with the veterinary and animal health communities to find ways to maintain the effectiveness of antiparasitic drugs in livestock and horses in the U.S. For more information about the FDA’s efforts to address antiparasitic resistance, please see the FDA’s webpage on Antiparasitic Resistance

Following is the letter Texas A&M System Chancellor John Sharp sent to Harvard President Lawrence S. Bacow.----------------------------------------Dr. Lawrence S. BacowPresidentHarvard UniversityMassa

The United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) is announcing the progress the agency is making to implement programs funded by the 2018 Farm

A new program administered by the National Institute of Antimicrobial Resistance Research and Education (NIAMRRE), will soon give producers a better way to demonstrate to consumers that they follow re

The U.S. Food and Drug Administration continues to work with stakeholders to address antiparasitic resistance in livestock (cattle, sheep, goats, swine, and poultry) and horses. In an on-going effort

In a move to address the dramatic global demand for safe, high-quality protein-based food sources, Colorado State University has announced the creation of a first-of-its-kind collaborative to support

The Texas Higher Education Coordinating Board (THECB) on Wednesday (Dec. 11) adopted the recommendation of the Committee on Academic and Workforce Success (CAWS) to approve the request from Texas Tech

FDA’s annual summary report on antimicrobial sales for use in food animals shows a small year-over-year increase in 2018, but the total remains well below pre-VFD levels. According to the report’s

After nearly two years of planning, development and implementation of a cattle disease traceability infrastructure, CattleTrace is inviting all beef industry stakeholders to attend the first-ever Catt

Use of antibiotics is under heightened scrutiny due to the increased prevalence of antibiotic-resistant pathogens. While the primary focus is on more stringent use of antibiotics in medical settings,

On Monday, September 23, the FDA released draft guidance for industry (GFI) #263, outlining a process for voluntarily bringing remaining approved animal drugs containing antimicrobials of human medica

The FDA’s Center for Veterinary Medicine this week issued a final rule, “New Animal Drugs; Updating Tolerances for Residues of New Animal Drugs in Food.” The final rule standardizes and clarifie

The U.S. Food and Drug Administration has approved Monovet 90, manufactured by Huvepharma EOOD, the first generic monensin for use in cattle and goats.In its approval notice, the FDA notes that Monens

Dale Grotelueschen, DVM, MS, retires this week, following a distinguished career serving the beef cattle industry. Since 2003, Grotelueschen has served as director of the University of Nebraska’s Gr

The PEW Charitable Trusts, long involved in public health and antibiotics policy, encourages the FDA to follow through with its plans to adopt a “biomass method” for measuring and analyzing antibi

Poultry’s status as a presumed “healthier” meat could be coming to an end. People have long assumed that poultry, with lower levels of saturated fatty acids compared with most red meats, would c

In recent months, APHIS has revised the Animal Disease Traceability program standards for approving new tags entering the market, with the following goals:Assure that quality devices are approved. Es

The following commentary does not necessarily reflect the views of AgWeb or Farm Journal. The opinions expressed below are the author's own.This week, the Council for Agricultural Science and Technolo

The USDA's Animal and Plant Health Inspection Service (APHIS) is announcing the availability of $1 million in cooperative agreement funding to support animal disease traceability (ADT) and electronic

The JBS Global Food Innovation Center In Honor of Gary & Kay Smith officially opened on the Colorado State University campus Tuesday, April 9, when JBS USA CEO Andre Nogueira cut the ribbon on the $20

USDA Farm Service Agency (FSA) State Executive Director Nancy Johner this week announced that emergency grazing of Conservation Reserve Program (CRP) acres is authorized for all Nebraska counties, due